Literature DB >> 8202037

Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old.

R D Hain1, L Rayner, S Weitzman, A Lorenzana.   

Abstract

Acute tumour lysis syndrome (ATLS) is a common complication of the treatment of haematopoietic malignancies. It is also well recognized in many nonhaematopoeitic malignancies of adults. There are very few reports of the syndrome occurring during therapy for the nonhaematopoeitic malignancies of childhood, and none has previously been reported in the treatment of neuroblastoma. We report the cases of four patients presenting to The Hospital for Sick Children (HSC) between 1985 and 1992 who developed ATLS during treatment for stage IVS neuroblastoma. ATLS is a significant risk in patients undergoing therapy for stage IVS neuroblastoma, particularly where this has been delayed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202037     DOI: 10.1002/mpo.2950230213

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

1.  Acute tumour lysis syndrome with no evidence of tumour load.

Authors:  R D Hain; E Harvey; A O Poon; S Weitzman
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

2.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

3.  Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature.

Authors:  Axel Cailleteau; Cyrille Touzeau; Bastien Jamet; Valentine Guimas; Emmanuel Jouglar; Stéphane Supiot
Journal:  Clin Transl Radiat Oncol       Date:  2021-11-12

Review 4.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.